Browsing by Ajou Author

김, 혜진(Kim, Hae Jin) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Endocrinology & Metabolism]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 1 to 20 of 131

This table browses all dspace content
Pub YearTitleAuthor(s)
2024A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)김혜진
2023Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells강엽, 김혜진, 이관우, 전자영, 최성이
2023Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension김혜진
20232023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association김대중, 김혜진
2023Amphiregulin Induces iNOS and COX-2 Expression through NF- κ B and MAPK Signaling in Hepatic Inflammation강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2023Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients김대중, 김혜진, 박범희, 이관우, 전자영, 한승진
2023Association between Low-Density Lipoprotein Cholesterol Level and Cardiovascular Outcomes in Korean Adults: A Nationwide Cohort Study김혜진
2023Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus김혜진
2022Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study김대중, 김혜진, 이관우, 이나미, 전자영, 한승진
2022Mitochondrial protease ClpP supplementation ameliorates diet-induced NASH in mice강엽, 김혜진, 이관우, 이광, 최성이, 한승진
2022Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study김혜진
2022The Positive Association between Muscle Mass and Bone Status Is Conserved in Men with Diabetes: A Retrospective Cross-Sectional and Longitudinal Study김대중, 김혜진, 정윤석, 최용준, 한승진
2022Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2022In Vivo Two-Photon Imaging Analysis of Dynamic Degradation of Hepatic Lipid Droplets in MS-275-Treated Mouse Liver강엽, 곽종영, 김혜진, 이관우, 전자영, 최성이
2022Development and psychometric evaluation of a new brief scale to measure eHealth literacy in people with type 2 diabetes김혜진, 이관우, 이은현
2021Acute glucose shift induces the activation of the nlrp3 inflammasome in thp-1 cells강엽, 김대중, 김혜진, 이관우, 한승진
2021Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF- κ B, MKK7/JNK, and JAK2/STAT1 Signalling Pathways강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model강엽, 김대중, 김혜진, 이관우, 이나미, 전자영, 최성이, 한승진, 허유정
2021Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors김혜진
1 2 3 4 5 6 7

Browse